Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Resonant Medical

Request full access

3D ultrasound image-guided adaptive radiotherapy products manufacturer

Montreal, CanadaFounded 1996

About Resonant Medical

Resonant Medical Inc., founded in 2000 and based in Montreal, Canada, developed and commercialized 3D ultrasound image-guided adaptive radiotherapy products. The company was established based on research from McGill University. One of the founders was Tony Falco, Ph.D., who served as the company's CEO and had over 15 years of experience in advanced imaging technology. He created a 3D and 4D imaging technology to better target tumors while sparing healthy tissue, an improvement over the imprecise X-ray imaging of the late 1990s.

The company's main product was the Clarity system, a non-invasive, radiation-free image guidance solution for conformal cancer treatments. This system was developed to provide superior visualization of soft tissue anatomy during the radiotherapy process, improving treatment accuracy for cancers such as prostate, breast, liver, and cervix. The technology was compatible with linear accelerators and CT scanners from all manufacturers. Resonant Medical's products, including the FDA-cleared Restitu Platform, were used in cancer centers and academic institutions across North America and Europe.

In December 2005, Resonant Medical secured a significant Series B funding round of $24 million from investors including Ventures West, MDS Capital, Lumira Ventures, and Rosetta Capital. This investment was aimed at expanding its product applications for head & neck, breast, and gynecological cancers. On March 31, 2010, the company was acquired by Elekta AB, a Swedish human-care company, for CAD 30 million (approximately $29.4M USD). The acquisition integrated Resonant's soft tissue visualization technology into Elekta's portfolio of cancer treatment solutions.

Source: Dealroom company data

Resonant Medical in the Montreal ecosystem

Live from Dealroom

The Resonant Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Bank Of Canada
  • MMV Financial
  • Desjardins Capital
  • MDS Capital
  • Ventures West
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇦 Canada100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Resonant Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Resonant Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.